Cargando…
Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897836/ https://www.ncbi.nlm.nih.gov/pubmed/35259538 http://dx.doi.org/10.1016/j.jaip.2022.02.030 |
| _version_ | 1784663513230213120 |
|---|---|
| author | Gernez, Yael Murugesan, Kanagavel Cortales, Cristina R. Banaei, Niaz Hoyte, Lisa Pinsky, Benjamin A. Lewis, David B. Pham, Michele N. |
| author_facet | Gernez, Yael Murugesan, Kanagavel Cortales, Cristina R. Banaei, Niaz Hoyte, Lisa Pinsky, Benjamin A. Lewis, David B. Pham, Michele N. |
| author_sort | Gernez, Yael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8897836 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Academy of Allergy, Asthma & Immunology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88978362022-03-07 Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects Gernez, Yael Murugesan, Kanagavel Cortales, Cristina R. Banaei, Niaz Hoyte, Lisa Pinsky, Benjamin A. Lewis, David B. Pham, Michele N. J Allergy Clin Immunol Pract Clinical Communications American Academy of Allergy, Asthma & Immunology 2022-05 2022-03-05 /pmc/articles/PMC8897836/ /pubmed/35259538 http://dx.doi.org/10.1016/j.jaip.2022.02.030 Text en © 2022 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Clinical Communications Gernez, Yael Murugesan, Kanagavel Cortales, Cristina R. Banaei, Niaz Hoyte, Lisa Pinsky, Benjamin A. Lewis, David B. Pham, Michele N. Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects |
| title | Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects |
| title_full | Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects |
| title_fullStr | Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects |
| title_full_unstemmed | Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects |
| title_short | Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects |
| title_sort | immunogenicity of a third covid-19 messenger rna vaccine dose in primary immunodeficiency disorder patients with functional b-cell defects |
| topic | Clinical Communications |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897836/ https://www.ncbi.nlm.nih.gov/pubmed/35259538 http://dx.doi.org/10.1016/j.jaip.2022.02.030 |
| work_keys_str_mv | AT gernezyael immunogenicityofathirdcovid19messengerrnavaccinedoseinprimaryimmunodeficiencydisorderpatientswithfunctionalbcelldefects AT murugesankanagavel immunogenicityofathirdcovid19messengerrnavaccinedoseinprimaryimmunodeficiencydisorderpatientswithfunctionalbcelldefects AT cortalescristinar immunogenicityofathirdcovid19messengerrnavaccinedoseinprimaryimmunodeficiencydisorderpatientswithfunctionalbcelldefects AT banaeiniaz immunogenicityofathirdcovid19messengerrnavaccinedoseinprimaryimmunodeficiencydisorderpatientswithfunctionalbcelldefects AT hoytelisa immunogenicityofathirdcovid19messengerrnavaccinedoseinprimaryimmunodeficiencydisorderpatientswithfunctionalbcelldefects AT pinskybenjamina immunogenicityofathirdcovid19messengerrnavaccinedoseinprimaryimmunodeficiencydisorderpatientswithfunctionalbcelldefects AT lewisdavidb immunogenicityofathirdcovid19messengerrnavaccinedoseinprimaryimmunodeficiencydisorderpatientswithfunctionalbcelldefects AT phammichelen immunogenicityofathirdcovid19messengerrnavaccinedoseinprimaryimmunodeficiencydisorderpatientswithfunctionalbcelldefects |